Solmaz Çelebi

Solmaz Çelebi

Auto-generated profile, based on publicly available information

Solmaz Çelebi

Department of Pediatric Infectious Diseases, Faculty of Medicine, Bursa Uludağ University, 16059 Bursa, Turkey

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2007 in Mycoses
Verified
Journal Article
Closed access
PDF file
SCSolmaz Celebi
Solmaz Celebi
MHMustafa Hacimustafaoglu
Mustafa Hacimustafaoglu
OOOzlem Ozdemir
Ozlem Ozdemir
GOGuven Ozkaya
Guven Ozkaya

4 March 2013 in Pediatric Hematology and Oncology
Verified
Journal Article
Closed access
SCSolmaz Celebi
Solmaz Celebi
MSMelike Evim Sezgin
Melike Evim Sezgin
DCDeniz Cakır
Deniz Cakır
BBBirol Baytan
Birol Baytan
MDMetin Demirkaya
Metin Demirkaya
MHMustafa Hacimustafaoglu
Mustafa Hacimustafaoglu
Catheter-associated bloodstream infections (CABSIs) are common complications encountered with cancer treatment. The aims of this study were to analyze the factors associated with recurrent infection and catheter removal in pediatric hematology-oncology patients. All cases of CABSIs in patients attending the Department of Pediatric Hematology-Oncology between January 2008 and December 2010 were reviewed. A total of 44 episodes of CABSIs, including multiple episodes involving the same catheter, were identified in 31 children with cancer. The overall CABSIs rate was 7.4 infections per 1000 central venous catheter (CVC) days. The most frequent organism isolated was coagulase-negative Staphylococcus (CONS). The CVC was removed in nine (20.4%) episodes. We found that hypotension, persistent bacteremia, Candida infection, exit-side infection, neutropenia, and prolonged duration of neutropenia were the factors for catheter removal. There were 23 (52.2%) episodes of recurrence or reinfection. Mortality rate was found to be 9.6% in children with CABSIs. In this study, we found that CABSIs rate was 7.4 infections per 1000 catheter-days. CABSIs rates in our hematology-oncology patients are comparable to prior reports. Because CONS is the most common isolated microorganism in CABSIs, vancomycin can be considered part of the initial empirical regimen.

14 June 2010 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
SCSolmaz Celebi
Solmaz Celebi
MHMustafa Hacimustafaoglu
Mustafa Hacimustafaoglu
NKNilgun Koksal
Nilgun Koksal
HOHilal Ozkan
Hilal Ozkan
MÇMerih Çetinkaya
Merih Çetinkaya

9 February 2012 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
SCSolmaz Celebi
Solmaz Celebi
MHMustafa Hacimustafaoglu
Mustafa Hacimustafaoglu
NKNilgun Koksal
Nilgun Koksal
HOHilal Ozkan
Hilal Ozkan
MÇMerih Çetinkaya
Merih Çetinkaya
BEBeyza Ener
Beyza Ener

5 January 2009 in Indian Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
SCS. Celebi
S. Celebi
MHM. Hacimustafaoglu
M. Hacimustafaoglu
DAD. Aygun
D. Aygun
EAE. S. Arisoy
E. S. Arisoy
YKY. Karali
Y. Karali
MSM. Seringec
M. Seringec

1 May 2008 in Indian Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
SCSolmaz Celebi
Solmaz Celebi
MHMustafa Hacimustafaoglu
Mustafa Hacimustafaoglu